ALK-Abelló A/S (OTC:AKBLF – Get Free Report)’s stock price traded up 5.2% on Tuesday . The stock traded as high as $21.35 and last traded at $21.35. 500 shares changed hands during mid-day trading, an increase of 67% from the average session volume of 300 shares. The stock had previously closed at $20.30.
ALK-Abelló A/S Stock Performance
The business’s 50 day simple moving average is $21.27 and its 200-day simple moving average is $22.83.
ALK-Abelló A/S Company Profile
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Read More
- Five stocks we like better than ALK-Abelló A/S
- 3 Fintech Stocks With Good 2021 Prospects
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Investing in the High PE Growth Stocks
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
